CMMB - Chemomab jumps on FDA Fast Track tag for liver disease therapy
2023-11-15 07:55:27 ET
More on Chemomab Therapeutics
- Chemomab Therapeutics receives Nasdaq notice regarding minimum bid price requirement
- Seeking Alpha’s Quant Rating on Chemomab Therapeutics
- Historical earnings data for Chemomab Therapeutics
- Financial information for Chemomab Therapeutics
For further details see:
Chemomab jumps on FDA Fast Track tag for liver disease therapy